Impact of biosimilar medicinal products in the EU pharmaceutical market

Impact of biosimilar medicinal products in the EU pharmaceutical market

Even though the most important conditions for market uptake of biosimilars are driven by commercial factors, still, real clinical evidence, clear regulatory framework, and postmarketing data on the use of biosimilars will influence their market access.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2015-08, Vol.37 (8), p.e163-e163
Hauptverfasser: Grozdanova, A, Ancevska Netkovska, K, Sterjev, Z, Naumovska, Z, Kapedanovska Nestorovska, A, Suturkova, L.j
Format: Artikel
Sprache:eng
Schlagworte:
Competition
Internal Medicine
Market entry
Market penetration
Medical Education
Pharmaceutical industry
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Even though the most important conditions for market uptake of biosimilars are driven by commercial factors, still, real clinical evidence, clear regulatory framework, and postmarketing data on the use of biosimilars will influence their market access.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.462